Rankings
▼
Calendar
BHVN Q3 2020 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$18M
Gross Profit
$13M
76.0% margin
Operating Income
-$163M
-923.7% margin
Net Income
-$195M
-1105.0% margin
EPS (Diluted)
$-3.27
QoQ Revenue Growth
+82.1%
Balance Sheet
Total Assets
$782M
Total Liabilities
$936M
Stockholders' Equity
-$212M
Cash & Equivalents
$316M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$18M
$0
—
Gross Profit
$13M
$0
—
Operating Income
-$163M
-$90M
-80.4%
Net Income
-$195M
-$106M
-83.9%
← FY 2020
All Quarters
Q4 2020 →